<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE ArticleSet PUBLIC "-//NLM//DTD PubMed 2.7//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/in/PubMed.dtd">
<ArticleSet>
<Article>
<Journal>
				<PublisherName>West Asia Organization for Cancer Prevention (WAOCP), APOCP's West Asia Chapter.</PublisherName>
				<JournalTitle>Asian Pacific Journal of Cancer Prevention</JournalTitle>
				<Issn>1513-7368</Issn>
				<Volume>16</Volume>
				<Issue>5</Issue>
				<PubDate PubStatus="epublish">
					<Year>2015</Year>
					<Month>05</Month>
					<Day>01</Day>
				</PubDate>
			</Journal>
<ArticleTitle>Association between the NQO1 C609T Polymorphism with Hepatocellular Carcinoma Risk in the Chinese Population</ArticleTitle>
<VernacularTitle></VernacularTitle>
			<FirstPage>1821</FirstPage>
			<LastPage>1825</LastPage>
			<ELocationID EIdType="pii">30669</ELocationID>
			
			
			<Language>EN</Language>
<AuthorList>
</AuthorList>
				<PublicationType>Journal Article</PublicationType>
			<History>
				<PubDate PubStatus="received">
					<Year>1970</Year>
					<Month>01</Month>
					<Day>01</Day>
				</PubDate>
			</History>
		<Abstract>&lt;b&gt;Background:&lt;/b&gt; Associations between the NQO1 C609T polymorphism and hepatocellular carcinoma (HCC)risk are a subject of debate. We therefore performed the present meta-analysis to evaluate links with HCCsusceptibility. Materials and &lt;br/&gt;&lt;b&gt;Methods&lt;/b&gt;: Several major databases (PubMed, EBSCO), the Chinese nationalknowledge infrastructure (CNKI) and the Wanfang database were searched for eligible studies. Crude odds ratios(ORs) with 95% confidence intervals (CIs) were used to measure the strength of associations. &lt;br/&gt;&lt;b&gt;Results&lt;/b&gt;: A total of4 studies including 1,325 patients and 1,367 controls were identified. There was a significant association betweenNQO1 C609T polymorphism and HCC for all genetic models (allelic model: OR=1.45, 95%CI=1.23-1.72, p&lt;0.01;additive model: OR=1.96, 95%CI=1.57-2.43, p&lt;0.01; dominant model: OR=1.62, 95%CI=1.38-1.91, p&lt;0.01; andrecessive model: OR=1.53, 95%CI=1.26-1.84, p&lt;0.01). On subgroup analysis, similarly results were identified inAsians. For Asians, the combined ORs and 95% CIs were (allelic model: OR=1.50, 95%CI=1.24-1.82, p&lt;0.01;additive model: OR=2.11, 95%CI=1.48-3.01, p&lt;0.01; dominant model: OR=1.69, 95%CI=1.42-2.02, p&lt;0.01;and recessive model: OR=1.59, 95%CI=1.16-2.19, p&lt;0.01). &lt;br/&gt;&lt;b&gt;Conclusions&lt;/b&gt;: The current meta-analysis suggestedthat the NQO1 C609T polymorphism could be a risk factor for developing HCC, particularly in the Chinesepopulation.</Abstract>
		<ObjectList>
			<Object Type="keyword">
			<Param Name="value">Hepatocellular carcinoma</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">NQO1</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Polymorphism</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Meta-analysis</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Chinese</Param>
			</Object>
		</ObjectList>
<ArchiveCopySource DocType="pdf">https://journal.waocp.org/article_30669_350d977b7ac92cc1a1d57843909665fd.pdf</ArchiveCopySource>
</Article>
</ArticleSet>
